APA

Chakraborty S., Rendón-Ramírez A., Ásgeirsson B., Dutta M., Ghosh A. S., Oda M., Venkatramani R., Rao B. J., Dandekar A. M. & Goñi F. M. (20150211). Dipeptidyl peptidase-IV inhibitors used in type-2 diabetes inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. : F1000Research.

Chicago

Chakraborty Sandeep, Rendón-Ramírez Adela, Ásgeirsson Bjarni, Dutta Mouparna, Ghosh Anindya S, Oda Masataka, Venkatramani Ravindra, Rao Basuthkar J, Dandekar Abhaya M and Goñi Félix M. 20150211. Dipeptidyl peptidase-IV inhibitors used in type-2 diabetes inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. : F1000Research.

Harvard

Chakraborty S., Rendón-Ramírez A., Ásgeirsson B., Dutta M., Ghosh A. S., Oda M., Venkatramani R., Rao B. J., Dandekar A. M. and Goñi F. M. (20150211). Dipeptidyl peptidase-IV inhibitors used in type-2 diabetes inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. : F1000Research.

MLA

Chakraborty Sandeep, Rendón-Ramírez Adela, Ásgeirsson Bjarni, Dutta Mouparna, Ghosh Anindya S, Oda Masataka, Venkatramani Ravindra, Rao Basuthkar J, Dandekar Abhaya M and Goñi Félix M. Dipeptidyl peptidase-IV inhibitors used in type-2 diabetes inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. : F1000Research. 20150211.